晚发型胎儿生长受限中产前皮质类固醇与围产期结局:前瞻性队列分析
本研究为TRUFFLE-2可行性研究的事后分析,纳入2017至2018年33个欧洲围产中心孕32+0至36+6周、有晚发型胎儿生长受限风险的孕妇。86例接受单疗程产前皮质类固醇者与86例未接受者按分娩孕周和出生体重匹配,复合不良结局发生率28% vs 24%(P=0.73),无显著差异。数据未显示类固醇对晚发型胎儿生长受限短期结局有益。
要点
- 晚发型胎儿生长受限孕妇接受产前皮质类固醇后复合不良结局28% vs 未接受者24%(P=0.73),无显著差异。
- 两组在出生时异常状况、主要新生儿疾病或围产期死亡的各组成部分均无显著差异。
- 数据未显示类固醇对晚发型胎儿生长受限胎儿的短期结局有有益影响。
核心结论
- 本研究数据未显示产前皮质类固醇对晚发型胎儿生长受限胎儿的短期结局有有益影响。
研究设计与样本
- 本研究为多中心前瞻性观察研究TRUFFLE-2可行性研究的二次分析,2017至2018年在33个欧洲围产中心开展。
- 纳入孕32+0至36+6周单胎、胎儿有晚发型胎儿生长受限风险(估计胎儿体重和/或腹围<第10百分位,或脐脑比≥第95百分位,或腹围较20周扫描下降超过40百分位点)的孕妇。
- 识别分娩前接受单疗程类固醇促胎肺成熟的孕妇86例,按分娩孕周和出生体重与86例未接受产前皮质类固醇的对照匹配。
主要发现
- 两组纳入时孕周33.1 vs 33.3周、估计胎儿体重1673 vs 1634 g、脐脑比0.68 vs 0.62,分娩孕周35.5 vs 35.9周、出生体重1925 vs 1948 g,均相似。
- 暴露组与非暴露组复合不良结局发生率28% vs 24%(P=0.73),无显著差异。
- 复合结局各组成部分在两组间均无显著差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the role of antenatal administration of corticosteroids for fetal lung maturation on the short-term perinatal outcome of pregnancy complicated by late fetal growth restriction (FGR). METHODS: This cohort study was a secondary analysis of a multicenter prospective observational study, the TRUFFLE-2 feasibility study, conducted between 2017 and 2018 in 33 European perinatal centers. The study included women with a singleton pregnancy from 32 + 0 to 36 + 6 weeks of gestation with a fetus considered at risk for FGR, defined as estimated fetal weight (EFW) and/or fetal abdominal circumference < 10th percentile, or umbilicocerebral ratio (UCR) ≥ 95th percentile or a drop of more than 40 percentile points in abdominal circumference measurement from the 20-week scan. For the purposes of the current study, we identified women who received a single course of steroids to improve fetal lung maturation before delivery. Each exposed pregnancy was matched with one that did not receive antenatal corticosteroids (ACS) (control), based on gestational age at delivery and birth weight. The primary adverse outcome was a composite of abnormal condition at birth, major neonatal morbidity or perinatal death. RESULTS: A total of 86 pregnancies that received ACS were matched to 86 controls. The two groups were similar with respect to gestational age (33.1 vs 33.3 weeks), EFW (1673 vs 1634 g) and UCR (0.68 vs 0.62) at inclusion, and gestational age at delivery (35.5 vs 35.9 weeks) and birth weight (1925 vs 1948 g). No significant differences were observed between the exposed and non-exposed groups in the incidence of composite adverse outcome (28% vs 24%; P = 0.73) or any of its elements. CONCLUSION: The present data do not show a beneficial effect of steroids on short-term outcome of fetuses with late FGR. © 2023 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Familiari A, Napolitano R, Visser GHA, et al. Antenatal corticosteroids and perinatal outcome in late fetal growth restriction: analysis of prospective cohort. Ultrasound Obstet Gynecol. 2023. PMID: 36412975. doi:10.1002/uog.26127
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。